Trademark Details For URSOFERRAN (Serial Number 79300278)

  •  Home
  •  Print
URSOFERRAN
  • Rank
    Global Trademark Influence Ranking
    4947
0
0
0
0
Serial Number  United States - USPTO 79300278
Registration Number 6504674
Mark
URSOFERRAN
Filing Date Nov-11-2020
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  




005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameRachel Jacques
AddressMASCHOFF BRENNAN 1389 CENTER DRIVE, SUITE 300 PARK CITY, UT 84098

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-19-2023INTERNATIONAL REGISTRATION RENEWED   RNWLP
Apr-10-2022FINAL DECISION TRANSACTION PROCESSED BY IB   FINVP
Mar-24-2022FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Mar-24-2022FINAL DISPOSITION PROCESSED   FIMPP
Jan-05-2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB   FICRP
Oct-05-2021REGISTERED-PRINCIPAL REGISTER   R.PRA
Jul-20-2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jul-20-2021PUBLISHED FOR OPPOSITION   PUBOA
Jun-30-2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jun-16-2021APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jun-16-2021TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Jun-16-2021CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Jun-16-2021TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
May-30-2021REFUSAL PROCESSED BY IB   RFNTP
May-08-2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB   RFCSP
May-06-2021REFUSAL PROCESSED BY MPU   RFRRP
May-04-2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW   RFCRE
May-03-2021
NON-FINAL ACTION WRITTEN
  
CNRTR
Apr-21-2021ASSIGNED TO EXAMINER   DOCKD
Dec-22-2020APPLICATION FILING RECEIPT MAILED   MAFRO
Dec-18-2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Dec-18-2020LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Dec-17-2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB   SDRCM